The 'G-CSF test': The response to a single dose of granulocyte colony- stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies

Experimental Hematology

Volumn 27, Issue 7, 1999, Pages 1204-1209

  Mijovic, Aleksandar ^a   Pagliuca, Antonio ^a   Mufti, Ghulam J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Good mobilizers; Granulocyte colony stimulating factor; Haemopoietic progenitors; Mobilization; Poor mobilizers

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

APHERESIS; ARTICLE; AUTOTRANSPLANTATION; BLOOD DISEASE; CHRONIC LYMPHATIC LEUKEMIA; COLONY FORMING UNIT; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOMA; MYELOMA; PRIORITY JOURNAL; STEM CELL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032982294     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00048-X     Document Type: Article

References (14)

1. To L.B., Haylock D.N., Simmons P.J., Juttner C.A. The biology and clinical uses of blood stem cells. Blood. 89:1997;2233.
2. + blood stem cell transplantation. Reiffers J., Goldman J.M., Armitage J.O. Blood stem cell transplantation. 1998;Martin Dunitz, London. 187p.
3. Haas R., Mohle R., Fruehauf S., Goldschmidt H., Witt B., Flentje M., Wannenmacher M., Hunstein W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 83:1994;3787.
4. Bensinger W., Appelbaum F., Rowley S., Storb R., Sanders J., Lilleby K., Gooley T., Demirer T., Schiffman K., Weaver C., Clift R., Chauncey T.et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol. 13:1995;2547.
5. Weaver C.H., Schwartzberg L.S., Birch R., Greco F.A., Rhinehart S., Hainsworth J., Beeker T., Price H., Geier L., Foster J., West J., Hazelton B.et al. Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor. an analysis of 497 patients Transfusion. 37:1997;896.
6. Drake M., Ranaghan L., Morris T.C.M., Nolan L., Desai Z.R., Irvine A.E., Jordan A., Magill K., Price S. Analysis of the effect of prior therapy on progenitor cell yields. use of a chemotherapy scoring system Br J Haematol. 98:1997;745.
7. Schwinger W., Mache C., Urban C., Beaufort F., Toglhofer W. Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant. 11:1993;489.
8. Watts M.J., Linch D.C. Peripheral blood stem cell transplantation. Vox Sang. 73:1997;135.
9. + cells by flow cytometry. application to the harvesting and transplantation of peripheral blood stem cells Wunder E., Sovalat H., Henon P.R., Serke S. Haemopoietic stem cells. the Mulhouse manual:1993;Alpha Med Press, Dayton, OH. 31p.
10. Watts M.J., Sullivan A.M., Leverett D., Peniket A.J., Perry A.R., Williams C.D., Devereux S., Goldstone A.H., Linch D.C. Back-up bone marrow is frequently ineffective in patients with poor peripheral blood stem-cell mobilisation. J Clin Oncol. 16:1998;1554.
11. Fruehauf S., Haas R., Conradt C., Murea S., Witt B., Mohle R., Hunstein W. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilised PBPC after Filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood. 85:1995;2619.
12. Husson B., Ravoet C., Dehon M., Wallef G., Hougardy N., Delannoy A. Predictive value of the steady-state peripheral blood progenitor cell (PBPC) counts for the yield of PBPC collected by leukapheresis after mobilization by granulocyte colony-stimulating factor (G-CSF) alone or chemotherapy and G-CSF (letter). Blood. 86:1995;3526.
13. Roberts A.W., Begley C.G., Grigg A.P., Basser R.L. Do steady-state peripheral blood progenitor cell (PBPC) counts predict the yield of PBPC mobilized by filgrastim alone? (letter). Blood. 86:1995;2451.
14. Jones H.M., Jones S.A., Watts M.J., Khwaja A., Mills W., Fielding A., Goldstone A.H., Linch D.C. Development of a simplified apheresis approach for PBSC transplantation in previously treated patients with lymphoma. J Clin Oncol. 12:1994;1693.